-
Company Insights
Newpaysafecard 2024 – Competitor Profile
paysafecard is one of the leading online prepaid voucher providers in Europe. Launched in Austria in 2000, it was acquired by Skrill Group in 2013 and became part of Paysafe Group through the latter’s acquisition of Skrill in 2015. Since then, paysafecard has been integrated into the group’s prepaid division. paysafecard allows consumers to convert cash into digital currency and pay for goods and services online without having to provide merchants with any bank or credit card details. Customers can...
-
Sector Analysis
NewFrance Cards and Payments – Opportunities and Risks to 2028
France Cards and Payments Market Report Overview The annual value of card transactions in the France cards and payments market was $857.59 billion in 2023. The French cards and payments industry is well developed. Multi-functional cards are a prominent feature of the French payment card market. The most common combination is debit and charge card facilities via a single payment card. Additionally, the growing adoption of contactless cards, the expansion of digital-only banks, the emergence of alternative payment solutions, and...
-
Sector Analysis
NewFinland Cards and Payments – Opportunities and Risks to 2028
Finland Cards and Payments Market Report Overview The annual value of card transactions in the Finland cards and payments market was $72.9 billion in 2023. The value is expected to grow at a CAGR of more than 4% during 2024-2028. Finland has a matured digital payments market facilitated by widespread familiarity with electronic payments, a highly banked population, and a well-established payment infrastructure. Finland Card Transactions Outlook, 2024-2028 ($ Billion) Buy the Full Report for More Information on the Finland...
-
Sector Analysis
NewNorway Cards and Payments – Opportunities and Risks to 2027
Norway Cards and Payments Market Report Overview The annual value of card transactions in the Norway cards and payments market was $121.1 billion in 2023. The value is expected to grow at a CAGR of more than 6% during 2023-2027. The government’s substantial investments in building long-term infrastructure for cashless transactions are driving the gradual rise in the popularity of electronic payments. Moreover, factors such as affordable and widely available financial products, the growing presence of digital-only banks, and consumer...
-
Sector Analysis
NewConstruction Market Size, Trends and Growth Forecasts by Regions and Countries, 2024-2028
This report provides a detailed analysis of the prospects for the global construction industry up to 2028. The challenging macroeconomic and geopolitical environment will see growth in the global construction industry slow in 2024. Real global construction output is anticipated to grow by 1.6%, having grown by 4.1% in 2023. Although the slowdown is being felt across many markets, growth in advanced economies is expected to be more impacted – with growth in 2024 falling by 1%, driven by lower...
-
Sector Analysis
NewJapan Cards and Payments – Opportunities and Risks to 2027
Japan Cards and Payments Market Report Overview The annual value of card transactions in the Japan cards and payments market was $793.6 billion in 2023. The value is expected to grow at a CAGR of more than 5% during 2023-2027. The growing adoption of contactless card payments for transport services will support card payment growth in the forecast period. Japan Card Transactions Outlook, 2023-2027 ($ Billion) Buy the Full Report for More Information on the Japan Cards and Payments Market...
-
Product Insights
NewPTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Report Overview A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. The PTCA Drug Coated Balloon (DCB) Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...
-
Product Insights
NewEndotracheal Tubes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Endotracheal Tubes Pipeline Market Report Overview Endotracheal tubes are used to maintain an unobstructed passageway especially to deliver oxygen or anesthesia to the lungs during surgery or any airway management procedure. The curved tube is placed through the patient's nose or mouth into the trachea (windpipe). The endotracheal tubes pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein...
-
Analyst Opinions
NewData Center Construction Project Insights and Analytics (Q1 2024)
This report provides a detailed analysis of data center construction projects globally, based on projects tracked by GlobalData. GlobalData is currently tracking a global pipeline of large-scale data center projects with a total value of $510.7 billion. The pipeline of projects includes all those with a value above $25 million, and at any stage from pre-planning through to execution. The pipeline of projects is relatively evenly balanced, with 57% in the pre-execution and execution stages, and 43% in the early...
-
Innovation Ranking
NewInnovation Ranking – ANI Pharmaceuticals Inc
ANI Pharmaceuticals Inc (ANI) is a specialty pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals. The company offers pharmaceuticals for central nervous system (CNS) disorders, gastrointestinal, cancer, ophthalmic, metabolic and other diseases. ANI also conducts business as a Contract Development and Manufacturing Organization (CDMO) supporting late-stage development to commercial manufacture of pharmaceutical products including coated/non-coated tablets and capsules, ointments, creams, non-sterile liquids, suspensions, and gels. It markets oncology products, complex formulations, hormones and steroids and controlled...